Tags

Type your tag names separated by a space and hit enter

[Current syphilis therapies and serological control. Commentary on the article by M. Hartmann in Hautarzt, Volume 2 (2004)].
Hautarzt. 2004 Nov; 55(11):1087-9.H

Abstract

Penicillin is currently the drug of choice for therapy of syphilis. Clemizole and procaine penicillin are no longer available. For this reason only benzathine penicillin and infusion therapy with benzyl penicillin are possible. Treatment with doxycyline or ceftriaxone is also conceivable. Suitable serological methods are necessary to control the safety of the therapy.

Authors+Show Affiliations

Klinik und Poliklinik für Dermatologie und Venerologie der Universität Rostock. prof.heise@web.de

Pub Type(s)

Comparative Study
English Abstract
Journal Article

Language

ger

PubMed ID

15448930

Citation

Heise, H. "[Current Syphilis Therapies and Serological Control. Commentary On the Article By M. Hartmann in Hautarzt, Volume 2 (2004)]." Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete, vol. 55, no. 11, 2004, pp. 1087-9.
Heise H. [Current syphilis therapies and serological control. Commentary on the article by M. Hartmann in Hautarzt, Volume 2 (2004)]. Hautarzt. 2004;55(11):1087-9.
Heise, H. (2004). [Current syphilis therapies and serological control. Commentary on the article by M. Hartmann in Hautarzt, Volume 2 (2004)]. Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete, 55(11), 1087-9.
Heise H. [Current Syphilis Therapies and Serological Control. Commentary On the Article By M. Hartmann in Hautarzt, Volume 2 (2004)]. Hautarzt. 2004;55(11):1087-9. PubMed PMID: 15448930.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Current syphilis therapies and serological control. Commentary on the article by M. Hartmann in Hautarzt, Volume 2 (2004)]. A1 - Heise,H, PY - 2004/9/28/pubmed PY - 2005/1/26/medline PY - 2004/9/28/entrez SP - 1087 EP - 9 JF - Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete JO - Hautarzt VL - 55 IS - 11 N2 - Penicillin is currently the drug of choice for therapy of syphilis. Clemizole and procaine penicillin are no longer available. For this reason only benzathine penicillin and infusion therapy with benzyl penicillin are possible. Treatment with doxycyline or ceftriaxone is also conceivable. Suitable serological methods are necessary to control the safety of the therapy. SN - 0017-8470 UR - https://www.unboundmedicine.com/medline/citation/15448930/[Current_syphilis_therapies_and_serological_control__Commentary_on_the_article_by_M__Hartmann_in_Hautarzt_Volume_2__2004_]_ L2 - https://dx.doi.org/10.1007/s00105-004-0834-0 DB - PRIME DP - Unbound Medicine ER -